Neurocognitive sequelae in African American and Caucasian children with multiple sclerosis
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective: To examine domain-specific neurocognitive differences between African American (AA) and Caucasian (CA) patients with pediatric-onset multiple sclerosis (POMS).
Methods: An extensive battery of neuropsychological tests was given to each subject, including tests in all major domains of cognitive function. Point-biserial correlations between ethnicity and test performance were computed. Significant correlations were followed up with hierarchical multiple regression analysis, accounting for clinical and demographic variables before examining ethnic differences.
Results: Forty-two patients with POMS including 20 AA and 22 CA subjects were assessed. The cohorts did not differ in age, gender, socioeconomic status, disease duration, disability score, immunoglobulin G index, or number of relapses in the first 2 years of disease. Retaining some of these variables as covariates in the hierarchical regression analysis, the AA cohort performed worse on measures of language (p < 0.001) and complex attention (p < 0.01) than their CA peers.
Conclusion: AA patients with POMS may be at higher risk for adverse cognitive impact in the areas of language and complex attention. Longitudinal characterization of cognitive pathology is critical for the development of effective intervention strategies to prolong cognitive functioning in POMS cohorts.
Footnotes
Study funding: Supported by the National Multiple Sclerosis Society Pediatric Center of Excellence.
-
Editorial, page 2054.
-
- AA
- African American
- AOMS
- adult-onset multiple sclerosis
- CA
- Caucasian
- CVLT-C
- California Verbal Learning Test–Children's Version
- D-KEFS
- Delis-Kaplan Executive Function System
- EDSS
- Expanded Disability Status Scale
- EOWPVT
- Expressive One-Word Picture Vocabulary Test
- IgG
- immunoglobulin G
- POMS
- pediatric-onset multiple sclerosis
- SES
- socioeconomic status
- VIQ
- verbal IQ
- WASI
- Wechsler Abbreviated Scale of Intelligence
- Received May 11, 2010.
- Accepted August 11, 2010.
- Copyright © 2010 by AAN Enterprises, Inc.
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Long-term Safety and Efficacy of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease
Dr. Marianne de Visser and Dr. Maudy Theunissen
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Clinical and Ethical Challenges
Multiple sclerosis in US minority populationsClinical practice insightsOmar Khan, Mitzi J. Williams, Lilyana Amezcua et al.Neurology: Clinical Practice, January 16, 2015 -
Article
Risk genes associated with pediatric-onset MS but not with monophasic acquired CNS demyelinationE. Daniëlle van Pelt, Julia Y. Mescheriakova, Nalia Makhani et al.Neurology, November 06, 2013 -
Contemporary Issues in Practice, Education, & Research
Factors Associated With, and Mitigation Strategies for, Health Care Disparities Faced by Patients With Headache DisordersJessica Kiarashi, Juliana VanderPluym, Christina L. Szperka et al.Neurology, June 09, 2021 -
Article
Long-term disability progression of pediatric-onset multiple sclerosisKyla A. McKay, Jan Hillert, Ali Manouchehrinia et al.Neurology, May 15, 2019